97320 ⎘
Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
CELL MEMBRANE PENETRATING CONJUGATES FOR GENE EDITING
#2LIGHT-RESPONSIVE POLYPEPTIDES AND METHODS OF USE THEREOF
#3FUSION PROTEIN FOR INDUCING IMMUNE RESPONSE AND TREATING CANCER
#4PROTEIN-BASED T-CELL RECEPTOR KNOCKDOWN
#5LIGAND GATED ION CHANNELS AND METHODS OF USE
#6Method of Co-Expressing a Sulfatase and a Sulfatase Modifying Factor in a Plant or Plant Cell
#7MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES
#8Cell Selection Methods and Related Compositions
#9DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#10Engineered and Fully-Functional Customized Glycoproteins
#11BLOCKADE OF CD7 EXPRESSION AND CHIMERIC ANTIGEN RECEPTORS FOR IMMUNOTHERAPY OF T-CELL MALIGNANCIES
#12ENGINEERED IMMUNE CELL
#13MEANS AND METHODS FOR REGULATING INTRACELLULAR TRAFFICKING OF SECRETORY OR CELL MEMBRANE-ANCHORED PROTEINS OF INTEREST
#14RECOMBINANT POLYPEPTIDES FOR REGULATABLE CELLULAR LOCALIZATION
#15Hook fusion protein for regulating the cellular trafficking of a target protein
#16MODIFIED NK-92 CELLS FOR TREATING CANCER
#17T CELL RECEPTOR-DEFICIENT CHIMERIC ANTIGEN RECEPTOR T-CELLS AND METHODS OF USE THEREOF
#18ENGINEERED T CELLS, AND PREPARATION AND USE THEREOF
#19Protease-controlled Secretion and Display of Intercellular Signals
#20NON-HUMAN ANIMAL SECRETOME MODELS
#21METHODS FOR PREDICTING KINASE INHIBITOR RESISTANCE
#22CLEAVABLE PEPTIDES AND INSECTICIDAL AND NEMATICIDAL PROTEINS COMPRISING SAME
#23Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies
#24MHC class I epitope delivering polypeptides
#25De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals
#26Method of co-expressing a sulfatase and a sulfatase modifying factor in a plant or plant cell
#27Recombinant vector for expressing target protein in plant cell
#28Light-responsive polypeptides and methods of use thereof
#29CELL MEMBRANE PENETRATING CONJUGATES FOR GENE EDITING
#30Engineered and fully-functional customized glycoproteins
#31MHC class I epitope delivering polypeptides
#32Blockade of CD2 surface expression and expression of chimeric antigen receptors for immunotherapy of T-cell malignancies
#33RECOMBINANT FUSION PROTEIN AND IMMUNOGENIC COMPOSITION
#34Modified NK-92 cells for treating cancer
#35Recombinant vector for expressing target protein in plant cell
#36Protein-based T-cell receptor knockdown
#37HOOK FUSION PROTEIN FOR REGULATING THE CELLULAR TRAFFICKING OF A TARGET PROTEIN
#38CELL COMPRISING A CHIMERIC ANTIGEN RECEPTOR (CAR)
#39CALRETICULIN AND FUSION PROTEINS
#40Fusion protein for improving protein expression from target mRNA
#41Cleavable peptides and insecticidal and nematicidal proteins comprising same
#42Production of highly thermally stable recombinant cholinesterases for the detection, detoxification and decontamination of organophosphorus compounds
#43Methods for predicting kinase inhibitor resistance
#44MHC Class I Epitope Delivering Polypeptides
#45Polypeptides Having Immunoactivating Activity And Methods Of Producing The Same
#46Opsin polypeptides and methods of use thereof
#47T cell receptor-deficient chimeric antigen receptor T-cells and methods of use thereof
#48CONTROL AND CHARACTERIZATION OF MEMORY FUNCTION
#49T CELL RECEPTOR-DEFICIENT CHIMERIC ANTIGEN RECEPTOR T-CELLS AND METHODS OF USE THEREOF
#50ENDOPLASMIC RETICULUM LOCALIZATION SIGNALS
#51Cleavable peptides and insecticidal and nematicidal proteins comprising same
#52Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
#53Light-responsive polypeptides and methods of use thereof
#54Opsin polypeptides and methods of use thereof
#55Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies
#56Modified NK-92 cells for treating cancer
#57Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies
#58Compositions and Methods for the Intracellular Disruption of VEGF and VEGFR-2 by Intraceptors
#59NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR
#60Nucleic acid construct
#61Protein-based T-cell receptor knockdown
#62Hepatitis B therapeutic vaccines
#63Opsin polypeptides and methods of use thereof
#64Transgenic microalgae and use thereof for oral delivery of proteins
#65Fluorescent fusion polypeptide, encoding nucleic acid, and cell comprising said polypeptide
#66Fluorescent fusion polypeptide, encoding nucleic acid, and cell comprising said polypeptide
#67High-throughput screening of functional antibody fragments, immunoconjugate comprising the same, and adaptor-drug conjugate for screening
#68Compositions and cell-based methods for monitoring the activity of a Dengue Virus protease
#69Protein muNS that can form inclusions in the endoplasmic reticulum, methods for the use thereof and uses of same
#70Endoplasmic Reticulum Localization Signals
#71MATERIALS AND METHODS FOR TREATING DISORDERS ASSOCIATED WITH SULFATASE ENZYMES
#72Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
#73Production of highly thermally stable recombinant cholinesterases for the detection, detoxification and decontamination of organophosphorus compounds
#74Opsin polypeptides and methods of use thereof
#75Dual specific immunotoxin for brain tumor therapy
#76Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#77Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases
#78Modified P450 reductase with N-terminal deletions and endoplasmic reticulum retention tag
#79Metal ion sensors and methods of detecting metal ions
#80Recombinant protein bodies as immunogen-specific adjuvants
#81Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#82Human cellular models with biosensors
#83Compositions and methods for identifying enzyme and transport protein inhibitors
#84Endoplasmic reticulum localization signals
#85CHIMERIC POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
#86Fluorescent fusion polypeptide
#87Transgenic microalgae and use thereof for oral delivery of proteins
#88Fusion proteins of ciliate granule lattice proteins, granular protein particles thereof, and uses therefor
#89Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
#90ANTICANCER FUSION PROTEIN
#91Endoplasmic reticulum localization signals
#92Porcine circovirus type-2 (PCV2) subunit vaccine
#93Expression vector and method for producing protein
#94Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors
#95Dual specific immunotoxin for brain tumor therapy
#96Polypeptides having immunoactivating activity and methods of producing the same
#97Plant cell culture expressing human lysosomal proteins and uses thereof
#98Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#99Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#100B7-1-PE40KDEL exotoxin fusion gene-based DNA vaccine and the use thereof
#101Control and characterization of memory function
#102Anticancer fusion protein comprising trail
#103Dual Specific Immunotoxin for Brain Tumor Therapy
#104METHODS FOR PRODUCING MODIFIED GLYCOPROTEINS
#105Selection and characterization of novel plant-derived recombinant human interferons with broad spectrum activity
#106Human lysosomal proteins from plant cell culture
#107Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
#108METHODS AND KITS FOR REGULATING INTRACELLULAR TRAFFICKING OF A TARGET PROTEIN
#109Production of recombinant proteins in ciliates and uses thereof
#110Compositions and methods for identifying enzyme and transport protein inhibitors
#111Recombinant Protein Bodies as Immunogen-Specific Adjuvants
#112Human lysosomal proteins from plant cell culture
#113Endoplasmic reticulum localization signals
#114Human lysosomal proteins from plant cell culture
#115Soluble recombinant influenza antigens
#116Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents
#117METHODS FOR PRODUCING MODIFIED GLYCOPROTEINS
#118Polypeptides and methods for making the same
#119Expression systems for functional membrane polypeptides
#120Anticancer Combination Therapies
#121MULTICOMPONENT VACCINE
#122Chimerical peptidic molecules with antiviral properties against the viruses of the Flaviviridae family
#123Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
#124PRODUCTION OF HIGH MANNOSE PROTEINS IN PLANT CULTURE
#125Methods for producing modified glycoproteins
#126Dual Specific Immunotoxin for Brain Tumor Therapy
#127Anti-CD19 Antibody, Immunotoxin and Treatment Method
#128Production of high mannose proteins in plant culture and therapeutic uses thereof
#129Fusion antigen used as vaccine and method of making them
#130DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence
#131Chimeric G protein based rabies vaccine
#132Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors
#133Methods for producing modified glycoproteins
#134Anti-T Cell and Autoantigen Treatment of Autoimmune Disease
#135Endoplasmic reticulum localization signals
#136Fusion antigen used as vaccine
#137DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS
#138Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and Calreticulin
#139Human lysosomal proteins from plant cell culture
#140Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccine
#141Conformational and topological protein regulation
#142DNA encoding the human serine protease EOS
#143Methods for producing modified glycoproteins
#144CD19-specific immunotoxin and treatment method
#145Suppression of xenotransplant rejection
#146Method for producing modified glycoproteins
#147Polypeptides and methods for making the same
#148Production of high mannose proteins in plant culture
#149Methods for producing modified glycoproteins
#150Methods for producing modified glycoproteins
#151Compositions and methods for monitoring enzyme activity
#152Recombinant hepatitis a virus antigens obtained in plant cells
#153Protein isolation and purification
#154Production of proteins
#155Methods for producing modified glycoproteins
#156Fusion protein for inhibiting cervical cancer
#157Conformational and topological protein regulation
#158Membrane-anchored beta2 microglobulin covalently linked to mhc class 1 peptide epitopes
#159Selection of bacterial inner-membrane anchor polypeptides
#160Suppression of xenotransplant rejection
#161Compositions and methods for less immunogenic protein formulations
#162Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
#163KDEL receptor inhibitors
#164Zymogen activation system
#165Conformational and topological protein regulation
#166Conformational and topological protein regulation
#167Conformational and topological protein regulation
#168Vaccinia virus recombinant A33R protein and kit for diagnosing antibodies against orthopoxvirus comprising the same